Neurocrine Biosciences (NBIX) Operating Leases (2009 - 2026)
Neurocrine Biosciences (NBIX) posted Operating Leases of $392.3 million for Q3 2026, down 8.4% from $428.4 million a year earlier and down 2.4% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Operating Leases (2009 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences' Operating Leases came in at $415.3 million, down 8.7% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of 34.5% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Operating Leases was $455.1 million in FY2024 (+76.2%), $258.3 million in FY2023 (+176.3%), $93.5 million in FY2022 (-11.2%) and $105.3 million in FY2021 (+11.5%).
- The Q3 2026 figure stands as the lowest quarterly Operating Leases since Q3 2024.
- On a year-over-year basis, Operating Leases has declined in each of the last four quarters, with growth averaging 32.5% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q3 2024, with growth of 192.7%; the weakest was Q1 2023, with a decline of 11.8%.
- According to Business Quant data, Operating Leases for the three prior quarters was $401.8 million (Q2 2026), $406.2 million (Q1 2026) and $415.3 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 392.30 Mn |
| Jun 30, 2026 | 401.80 Mn |
| Mar 31, 2026 | 406.20 Mn |
| Dec 31, 2025 | 415.30 Mn |
| Sep 30, 2025 | 428.40 Mn |
| Jun 30, 2025 | 439.10 Mn |
| Mar 31, 2025 | 447.50 Mn |
| Dec 31, 2024 | 455.10 Mn |
| Sep 30, 2024 | 251.40 Mn |
| Jun 30, 2024 | 256.20 Mn |
| Mar 31, 2024 | 252.90 Mn |
| Dec 31, 2023 | 258.30 Mn |
| Sep 30, 2023 | 85.90 Mn |
| Jun 30, 2023 | 89.10 Mn |
| Mar 31, 2023 | 90.40 Mn |
| Dec 31, 2022 | 93.50 Mn |
| Sep 30, 2022 | 96.60 Mn |
| Jun 30, 2022 | 99.60 Mn |
| Mar 31, 2022 | 102.50 Mn |
| Dec 31, 2021 | 105.30 Mn |
API Access
Neurocrine Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();